Correlation Between Enliven Therapeutics and Biocardia
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Biocardia, you can compare the effects of market volatilities on Enliven Therapeutics and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Biocardia.
Diversification Opportunities for Enliven Therapeutics and Biocardia
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Biocardia is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Biocardia go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Biocardia
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.45 times more return on investment than Biocardia. However, Enliven Therapeutics is 2.2 times less risky than Biocardia. It trades about 0.04 of its potential returns per unit of risk. Biocardia is currently generating about -0.01 per unit of risk. If you would invest 1,652 in Enliven Therapeutics on September 1, 2024 and sell it today you would earn a total of 786.00 from holding Enliven Therapeutics or generate 47.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Biocardia
Performance |
| Timeline |
| Enliven Therapeutics |
| Biocardia |
Enliven Therapeutics and Biocardia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Biocardia
The main advantage of trading using opposite Enliven Therapeutics and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| Biocardia vs. Tff Pharmaceuticals | Biocardia vs. Eliem Therapeutics | Biocardia vs. Inhibrx | Biocardia vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |